Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI.

Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule JC, Chadjichristos CE, Prakoura N, Chatziantoniou C.

J Am Soc Nephrol. 2019 Nov 5. pii: ASN.2019020113. doi: 10.1681/ASN.2019020113. [Epub ahead of print]

PMID:
31690575
2.

Notch3 orchestrates epithelial and inflammatory responses to promote acute kidney injury.

Kavvadas P, Keuylian Z, Prakoura N, Placier S, Dorison A, Chadjichristos CE, Dussaule JC, Chatziantoniou C.

Kidney Int. 2018 Jul;94(1):126-138. doi: 10.1016/j.kint.2018.01.031. Epub 2018 May 8.

PMID:
29751972
3.

The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease.

Dorison A, Dussaule JC, Chatziantoniou C.

Nephron. 2017;137(3):212-220. doi: 10.1159/000479119. Epub 2017 Jul 26. Review.

4.

Decreased Expression of Connexin 43 Blunts the Progression of Experimental GN.

Kavvadas P, Abed A, Poulain C, Authier F, Labéjof LP, Calmont A, Afieri C, Prakoura N, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

J Am Soc Nephrol. 2017 Oct;28(10):2915-2930. doi: 10.1681/ASN.2016111211. Epub 2017 Jun 30.

5.

NFκB-Induced Periostin Activates Integrin-β3 Signaling to Promote Renal Injury in GN.

Prakoura N, Kavvadas P, Kormann R, Dussaule JC, Chadjichristos CE, Chatziantoniou C.

J Am Soc Nephrol. 2017 May;28(5):1475-1490. doi: 10.1681/ASN.2016070709. Epub 2016 Dec 5.

6.

Extracorporeal shock wave therapy does not improve hypertensive nephropathy.

Caron J, Michel PA, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Physiol Rep. 2016 Jun;4(11). pii: e12699. doi: 10.14814/phy2.12699.

7.

Protective effects of genetic inhibition of Discoidin Domain Receptor 1 in experimental renal disease.

Kerroch M, Alfieri C, Dorison A, Boffa JJ, Chatziantoniou C, Dussaule JC.

Sci Rep. 2016 Feb 16;6:21262. doi: 10.1038/srep21262.

8.

Searching novel diagnostic markers and targets for therapy of CKD.

Kavvadas P, Dussaule JC, Chatziantoniou C.

Kidney Int Suppl (2011). 2014 Nov;4(1):53-57. Review.

9.

Discoidin domain receptor-1 and periostin: new players in chronic kidney disease.

Alfieri C, Kavvadas P, Simonini P, Ikehata M, Dussaule JC, Chadjichristos CE, Rastaldi MP, Messa P, Chatziantoniou C.

Nephrol Dial Transplant. 2015 Dec;30(12):1965-71. doi: 10.1093/ndt/gfv074. Epub 2015 Mar 31. Review.

10.

Activation of Notch3 in Glomeruli Promotes the Development of Rapidly Progressive Renal Disease.

El Machhour F, Keuylian Z, Kavvadas P, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2015 Jul;26(7):1561-75. doi: 10.1681/ASN.2013090968. Epub 2014 Nov 24.

11.

Targeting connexin 43 protects against the progression of experimental chronic kidney disease in mice.

Abed A, Toubas J, Kavvadas P, Authier F, Cathelin D, Alfieri C, Boffa JJ, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Kidney Int. 2014 Oct;86(4):768-79. doi: 10.1038/ki.2014.108. Epub 2014 May 21.

12.

Connexins in renal endothelial function and dysfunction.

Abed A, Dussaule JC, Boffa JJ, Chatziantoniou C, Chadjichristos CE.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):15-21. Review.

PMID:
24720461
13.

Inhibition of periostin expression protects against the development of renal inflammation and fibrosis.

Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C.

J Am Soc Nephrol. 2014 Aug;25(8):1724-36. doi: 10.1681/ASN.2013060664. Epub 2014 Feb 27.

14.

Renin inhibition reverses renal disease in transgenic mice by shifting the balance between profibrotic and antifibrotic agents.

Kavvadas P, Weis L, Abed AB, Feldman DL, Dussaule JC, Chatziantoniou C.

Hypertension. 2013 Apr;61(4):901-7. doi: 10.1161/HYPERTENSIONAHA.111.00639. Epub 2013 Feb 25.

PMID:
23438929
15.

The RenTg mice: a powerful tool to study renin-dependent chronic kidney disease.

Huby AC, Kavvadas P, Alfieri C, Abed A, Toubas J, Rastaldi MP, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

PLoS One. 2012;7(12):e52362. doi: 10.1371/journal.pone.0052362. Epub 2012 Dec 26.

16.

Progression of renal fibrosis: the underestimated role of endothelial alterations.

Guerrot D, Dussaule JC, Kavvadas P, Boffa JJ, Chadjichristos CE, Chatziantoniou C.

Fibrogenesis Tissue Repair. 2012 Jun 6;5(Suppl 1):S15. doi: 10.1186/1755-1536-5-S1-S15. eCollection 2012.

17.

FXTAS: new insights and the need for revised diagnostic criteria.

Apartis E, Blancher A, Meissner WG, Guyant-Maréchal L, Maltête D, De Broucker T, Legrand AP, Bouzenada H, Thanh HT, Sallansonnet-Froment M, Wang A, Tison F, Roué-Jagot C, Sedel F, Charles P, Whalen S, Héron D, Thobois S, Poisson A, Lesca G, Ouvrard-Hernandez AM, Fraix V, Palfi S, Habert MO, Gaymard B, Dussaule JC, Pollak P, Vidailhet M, Durr A, Barbot JC, Gourlet V, Brice A, Anheim M.

Neurology. 2012 Oct 30;79(18):1898-907. doi: 10.1212/WNL.0b013e318271f7ff. Epub 2012 Oct 17.

PMID:
23077007
18.

Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.

Djudjaj S, Chatziantoniou C, Raffetseder U, Guerrot D, Dussaule JC, Boor P, Kerroch M, Hanssen L, Brandt S, Dittrich A, Ostendorf T, Floege J, Zhu C, Lindenmeyer M, Cohen CD, Mertens PR.

J Pathol. 2012 Nov;228(3):286-99. doi: 10.1002/path.4076. Epub 2012 Sep 7.

PMID:
22806125
19.

Genetic inhibition of discoidin domain receptor 1 protects mice against crescentic glomerulonephritis.

Kerroch M, Guerrot D, Vandermeersch S, Placier S, Mesnard L, Jouanneau C, Rondeau E, Ronco P, Boffa JJ, Chatziantoniou C, Dussaule JC.

FASEB J. 2012 Oct;26(10):4079-91. doi: 10.1096/fj.11-194902. Epub 2012 Jul 2.

PMID:
22751008
20.

Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction.

Bige N, Shweke N, Benhassine S, Jouanneau C, Vandermeersch S, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Kidney Int. 2012 Jun;81(12):1226-38. doi: 10.1038/ki.2012.21. Epub 2012 Mar 14.

21.

Identification of periostin as a critical marker of progression/reversal of hypertensive nephropathy.

Guerrot D, Dussaule JC, Mael-Ainin M, Xu-Dubois YC, Rondeau E, Chatziantoniou C, Placier S.

PLoS One. 2012;7(3):e31974. doi: 10.1371/journal.pone.0031974. Epub 2012 Mar 5.

22.

[Chronic kidney disease, new therapeutic approaches].

Boffa JJ, Dussaule JC, Ronco P, Chatziantoniou C.

Rev Prat. 2012 Jan;62(1):72-5. French.

PMID:
22335071
23.

Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis.

Bollée G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL.

Nat Med. 2011 Sep 25;17(10):1242-50. doi: 10.1038/nm.2491. Erratum in: Nat Med. 2011 Nov;17(11):1521. Nat Med. 2011 Oct;17(10):2 p following 1250.

24.

Discoidin domain receptor 1 is a major mediator of inflammation and fibrosis in obstructive nephropathy.

Guerrot D, Kerroch M, Placier S, Vandermeersch S, Trivin C, Mael-Ainin M, Chatziantoniou C, Dussaule JC.

Am J Pathol. 2011 Jul;179(1):83-91. doi: 10.1016/j.ajpath.2011.03.023. Epub 2011 May 13.

25.

Notch3 is essential for regulation of the renal vascular tone.

Boulos N, Helle F, Dussaule JC, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa JJ, Chatziantoniou C.

Hypertension. 2011 Jun;57(6):1176-82. doi: 10.1161/HYPERTENSIONAHA.111.170746. Epub 2011 Apr 25.

PMID:
21518968
26.

Alteration of connexin expression is an early signal for chronic kidney disease.

Toubas J, Beck S, Pageaud AL, Huby AC, Mael-Ainin M, Dussaule JC, Chatziantoniou C, Chadjichristos CE.

Am J Physiol Renal Physiol. 2011 Jul;301(1):F24-32. doi: 10.1152/ajprenal.00255.2010. Epub 2011 Mar 23.

27.

The role of cell plasticity in progression and reversal of renal fibrosis.

Dussaule JC, Guerrot D, Huby AC, Chadjichristos C, Shweke N, Boffa JJ, Chatziantoniou C.

Int J Exp Pathol. 2011 Jun;92(3):151-7. doi: 10.1111/j.1365-2613.2011.00760.x. Epub 2011 Feb 12. Review.

28.

Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.

Mihout F, Shweke N, Bigé N, Jouanneau C, Dussaule JC, Ronco P, Chatziantoniou C, Boffa JJ.

J Pathol. 2011 Jan;223(1):37-45. doi: 10.1002/path.2769. Epub 2010 Sep 15.

PMID:
20845411
29.

[Role of cell plasticity in progression and regression of renal fibrosis].

Dussaule JC, Guerrot D, Huby AC, Boffa JJ, Chatziantoniou C.

Bull Acad Natl Med. 2009 Dec;193(9):1993-2003; discussion 2003-4. French.

PMID:
20666013
30.

Restoration of podocyte structure and improvement of chronic renal disease in transgenic mice overexpressing renin.

Huby AC, Rastaldi MP, Caron K, Smithies O, Dussaule JC, Chatziantoniou C.

PLoS One. 2009 Aug 21;4(8):e6721. doi: 10.1371/journal.pone.0006721.

31.

Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.

Helle F, Jouzel C, Chadjichristos C, Placier S, Flamant M, Guerrot D, François H, Dussaule JC, Chatziantoniou C.

Am J Physiol Renal Physiol. 2009 Jul;297(1):F191-9. doi: 10.1152/ajprenal.00015.2009. Epub 2009 May 6.

32.

[Reversal of renal fibrosis: lessons from experimental models].

Dussaule JC, Chatziantoniou C.

Bull Acad Natl Med. 2008 May;192(5):987-1000; discussion 1000-1. French.

PMID:
19238788
33.

Tissue transglutaminase contributes to interstitial renal fibrosis by favoring accumulation of fibrillar collagen through TGF-beta activation and cell infiltration.

Shweke N, Boulos N, Jouanneau C, Vandermeersch S, Melino G, Dussaule JC, Chatziantoniou C, Ronco P, Boffa JJ.

Am J Pathol. 2008 Sep;173(3):631-42. doi: 10.2353/ajpath.2008.080025. Epub 2008 Aug 7.

34.

Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

Sabaa N, de Franceschi L, Bonnin P, Castier Y, Malpeli G, Debbabi H, Galaup A, Maier-Redelsperger M, Vandermeersch S, Scarpa A, Janin A, Levy B, Girot R, Beuzard Y, Leboeuf C, Henri A, Germain S, Dussaule JC, Tharaux PL.

J Clin Invest. 2008 May;118(5):1924-33. doi: 10.1172/JCI33308.

35.

Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations.

Roze E, Apartis E, Clot F, Dorison N, Thobois S, Guyant-Marechal L, Tranchant C, Damier P, Doummar D, Bahi-Buisson N, André-Obadia N, Maltete D, Echaniz-Laguna A, Pereon Y, Beaugendre Y, Dupont S, De Greslan T, Jedynak CP, Ponsot G, Dussaule JC, Brice A, Dürr A, Vidailhet M.

Neurology. 2008 Mar 25;70(13):1010-6. doi: 10.1212/01.wnl.0000297516.98574.c0.

PMID:
18362280
36.

Is kidney injury a reversible process?

Chatziantoniou C, Dussaule JC.

Curr Opin Nephrol Hypertens. 2008 Jan;17(1):76-81. Review.

PMID:
18090674
37.

[Renal and urinary tract disease national research program].

Stengel B, Antignac C, Baverel G, Choukroun G, Cussenot O, Dussaule JC, Friedlander G, Lang P, Lelièvre-Pégorier M, Massy Z, Monteiro R, Parini A, Soulillou JP, Baud L, Ronco P.

Nephrol Ther. 2007 Jul;3(4):157-62. Epub 2007 Jun 26. French.

PMID:
17658443
38.

Role of matrix metalloproteinases in early hypertensive vascular remodeling.

Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S.

Hypertension. 2007 Jul;50(1):212-8. Epub 2007 May 21.

PMID:
17515450
39.

Variation in natriuretic peptides and mitral flow indexes during successful ventilatory weaning: a preliminary study.

Ait-Oufella H, Tharaux PL, Baudel JL, Vandermeersch S, Meyer P, Tonnellier M, Dussaule JC, Guidet B, Offenstadt G, Maury E.

Intensive Care Med. 2007 Jul;33(7):1183-1186. doi: 10.1007/s00134-007-0627-x. Epub 2007 Apr 3.

PMID:
17404702
40.

Reversal of renal disease: is it enough to inhibit the action of angiotensin II?

Dussaule JC, Chatziantoniou C.

Cell Death Differ. 2007 Jul;14(7):1343-9. Epub 2007 Mar 30. Review.

41.

Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease.

Flamant M, Placier S, Rodenas A, Curat CA, Vogel WF, Chatziantoniou C, Dussaule JC.

J Am Soc Nephrol. 2006 Dec;17(12):3374-81. Epub 2006 Nov 8.

42.

[Renal hemodynamics and development of renal fibrotic lesions during hypertension].

Placier S, Flamant M, Boffa JJ, Dussaule JC, Chatziantoniou C.

Arch Mal Coeur Vaiss. 2006 Jul-Aug;99(7-8):697-700. French.

PMID:
17061447
43.

Heparin binding EGF is necessary for vasospastic response to endothelin.

Chansel D, Ciroldi M, Vandermeersch S, Jackson LF, Gomez AM, Henrion D, Lee DC, Coffman TM, Richard S, Dussaule JC, Tharaux PL.

FASEB J. 2006 Sep;20(11):1936-8. Epub 2006 Jul 28.

PMID:
16877529
44.

Reversal of renal lesions following interruption of nitric oxide synthesis inhibition in transgenic mice.

Placier S, Boffa JJ, Dussaule JC, Chatziantoniou C.

Nephrol Dial Transplant. 2006 Apr;21(4):881-8. Epub 2005 Dec 29.

PMID:
16384829
45.

Urinary endothelin-1 as a marker of renal damage in sickle cell disease.

Tharaux PL, Hagège I, Placier S, Vayssairat M, Kanfer A, Girot R, Dussaule JC.

Nephrol Dial Transplant. 2005 Nov;20(11):2408-13. Epub 2005 Sep 6.

PMID:
16144850
46.

Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?

Chatziantoniou C, Dussaule JC.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F227-34. Review.

47.

[Renal vascular and glomerular fibrosis and epidermal growth factor receptor transactivation].

Flamant M, Dussaule JC, Ardaillou R.

Med Sci (Paris). 2005 May;21(5):461-3. French. No abstract available.

48.

Progression and regression in renal vascular and glomerular fibrosis.

Chatziantoniou C, Boffa JJ, Tharaux PL, Flamant M, Ronco P, Dussaule JC.

Int J Exp Pathol. 2004 Feb;85(1):1-11. Review.

49.

Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.

François H, Placier S, Flamant M, Tharaux PL, Chansel D, Dussaule JC, Chatziantoniou C.

FASEB J. 2004 May;18(7):926-8. Epub 2004 Mar 19.

PMID:
15033924
50.

AT1 receptor expression in glomeruli from NO-deficient rats.

Vandermeersch S, Stefanovic V, Hus-Citharel A, Ardaillou R, Dussaule JC, Chansel D.

Nephron Exp Nephrol. 2003;95(3):e119-28.

PMID:
14646364

Supplemental Content

Loading ...
Support Center